CACI International Inc ( NYSE: CACI) announced today that it has signed a definitive agreement to acquire Emergint Technologies, Inc., a premier provider of emerging technology solutions focused on the data-driven needs of national health organizations. This acquisition builds on CACI’s healthcare IT capability and expands its presence in the growing healthcare IT market. Closing is anticipated by December 1, 2012.
Founded in 1999, Emergint is headquartered in Louisville, Kentucky. Its 300 professionals deliver a wide range of healthcare-focused IT-related services that support the missions of federal and state customers. The company has extensive experience providing health data integration and analysis solutions, data analytics, management and IT consulting, and data and records management. Emergint’s key customers include health-focused federal agencies such as the Centers for Disease Control and Prevention, National Institutes of Health, and U.S. Food and Drug Administration. Its 2012 revenue is expected to be approximately $42 million, and the acquisition is expected to be accretive to CACI’s earnings per share during its first 12 months.
John Mengucci, CACI Chief Operating Officer and President of U.S. Operations, said, “We are pleased to announce our intent to bring Emergint Technologies, Inc. into CACI. Their exceptional team, uncompromising commitment to integrity, and first-rate customer accountability make them a great fit for our company. Equally important, Emergint’s data analytics capability and long-standing relationships with national health organizations will expand our ability to provide quality healthcare IT solutions in support of our customers’ strategic missions.”
According to Dan Allen, CACI President and Chief Executive Officer, “The federal government is increasingly requiring high-value solutions to improve healthcare IT practices and systems that will, in turn, contribute to the public health and safety of our nation’s citizens. CACI’s acquisition of Emergint opens new opportunities in our high-growth healthcare IT market and enables us to serve an even greater share of this market.”
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts